{
    "2019-08-28": [
        [
            {
                "time": "",
                "original_text": "美年健康(002044.SZ)发布2019年半年报 聚焦主业营收稳步增至36.41亿元",
                "features": {
                    "keywords": [
                        "美年健康",
                        "半年报",
                        "聚焦主业",
                        "营收增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "美年健康：上半年净利润同比减89.40% 盈利能力下降",
                "features": {
                    "keywords": [
                        "美年健康",
                        "净利润下降",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中国体检大数据糖尿病地图首度发布 “四高四低”特征显著",
                "features": {
                    "keywords": [
                        "体检大数据",
                        "糖尿病地图",
                        "四高四低特征"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗健康",
                        "公共卫生"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【国元医药】 业务转型调整中，静待业绩拐点 ——美年健康 2019H1 点评",
                "features": {
                    "keywords": [
                        "国元医药",
                        "业务转型",
                        "业绩拐点",
                        "美年健康"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "开立医疗中报点评:经营低点已过,下半年高端产品有望放量驱动公司重拾较快增长",
                "features": {
                    "keywords": [
                        "开立医疗",
                        "中报点评",
                        "经营低点",
                        "高端产品放量",
                        "较快增长"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}